Zilkha Neurogenetic Institute (ZNI)
The Zilkha Neurogenetic Institute (ZNI) is one of the Centers of Excellence at the Keck School of Medicine of USC. Established in 2003 with a gift from Selim Zilkha, the Zilkha Neurogenetic Institute is a world leader for basic neuroscience research, with a multi-disciplinary team of outstanding faculty whose collaboration concentrates on the causes, effects of and therapies for neurodegenerative disease and psychiatric disorders.
Students work with world leading researchers in various disciplines to conduct world-class bench science with some clinical applications and translational work to investigate and identify the underlying circuitry or mechanisms of the brain that are influenced or affected by neurodegenerative conditions such as Alzheimer’s, Huntington’s disease, schizophrenia, autism, Down Syndrome and hearing and visual disorders. The research experience takes place in a vibrant and dynamic community with access to a variety of state-of-the-art labs and numerous resources.
Researchers clarify role of genetic risk factor in Alzheimer’s disease
Scientists at the Keck School of Medicine of USC have discovered that a protein known as PICALM regulates removal of toxic plaques from the brain, which could be a potential therapeutic target for the treatment of Alzheimer’s disease. In a study that appears in the May 25 edition of the scientific journal Nature Neuroscience, researchers
2015 Zach Hall Lecture with Dr. Roger Nicoll
The Lecture, one of ZNI’s signature events, offers students a day-long experience with scientific reports, seminars and poster sessions as well as opportunities to visit with established scientists such as neurology expert Dr. Roger Nicoll.